LET'S TALK. 303-429-6448

——————————————————————————————————————————————————————————————————————————————————————————————————————–
(1) Waterman BR, Belmont PJ, Schoenfeld AJ. Low back pain in the United States: incidence and risk factors for presentation in the emergency setting. Spine J. 2012;12(1):63-70.DOI: 10.1016/j.spinee.2011.09.002
(2) Chopra P, Tinkle B, Hamonet C, et al. Pain management in the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):212-9.DOI: 10.1002/ajmg.c.31554
(3) Zhou Z, Rewari A, Shanthanna H. Management of chronic pain in Ehlers-Danlos syndrome: Two case reports and a review of literature. Medicine (Baltimore). 2018;97(45):e13115.doi: 10.1097/MD.0000000000013115
(4) Tewari S, Madabushi R, Agarwal A, Gautam SK, Khuba S. Chronic pain in a patient with Ehlers-Danlos syndrome (hypermobility type): The role of myofascial trigger point injections. J Bodyw Mov Ther. 2017;21(1):194-6.DOI: 10.1016/j.jbmt.2016.06.017
(5) Laseter JT, Russell JA. Anabolic steroid-induced tendon pathology: a review of the literature. Med Sci Sports Exerc.1991;23(1):1-3.
(6) Singla V, Batra YK, Bharti N, Goni VG, Marwaha N. Steroid vs. Platelet-Rich Plasma in Ultrasound-Guided Sacroiliac Joint Injection for Chronic Low Back Pain. Pain Pract. 2017;17(6):782-91.DOI: 10.1111/papr.12526
(7) Ko GD, Mindra S, Lawson GE, Whitmore S, Arseneau L. Case series of ultrasound-guided platelet-rich plasma injections for sacroiliac joint dysfunction. J Back Musculoskelet Rehabil. 2017;30(2):363-70.DOI: 10.3233/BMR-160734

Receive an Info Packet by email and learn how our procedures can treat your condition!

Receive an Info Packet by email and learn how our procedures can treat your condition!

You have Successfully Subscribed!